By correlating imaging features with molecular markers such as VHL, PBRM1, and BAP1 mutations, AI facilitates non-invasive prediction of genetic profiles, paving the way for personalized treatment approaches in ccRCC. Here, PBRM1 is linked to nonpapillary renal cell carcinoma.